PSYCH Symposium: Challenges in Psychedelic Drug Development

Challenges in Psychedelic Drug Development: Psychedelics induce non-ordinary states of consciousness, which creates unique challenges in the design and conduct of research studies. This panel of experts explored some of the key challenges that are critical to good clinical development in this space.
Featuring:
Dr. Amir Inamdar, Chief Medical Officer, Cybin Inc.
Dr. Catherine Schuster-Bruce, Journalist, Business Insider.